KAYLA MARIE COOLEY

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family WIGGINS, MS NPI 1003404732

General Payments — all program years on this page

$1,939.32

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 114
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $670.14 across 40 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $595.1539
Education $74.991

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $30.142
2022 $426.8327
2023 $812.2145
2024 $670.1440

Records — PY2024 (40)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100287236 Novo Nordisk Inc $17.82 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100304337 Novo Nordisk Inc $13.97 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100308483 Novo Nordisk Inc $18.67 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100368011 Novo Nordisk Inc $19.63 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100378461 Novo Nordisk Inc $17.31 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100603822 Novo Nordisk Inc $15.64 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105555574 AstraZeneca Pharmaceuticals LP $16.40 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105687419 AstraZeneca Pharmaceuticals LP $14.01 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105727853 AstraZeneca Pharmaceuticals LP $18.47 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106948936 ABBVIE INC. $22.57 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106948938 ABBVIE INC. $21.40 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113926598 Paratek Pharmaceuticals, Inc. $14.63 12/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115876729 GlaxoSmithKline, LLC. $6.76 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116041927 GlaxoSmithKline, LLC. $11.37 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116350388 GlaxoSmithKline, LLC. $11.92 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116449805 GlaxoSmithKline, LLC. $16.60 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116456481 GlaxoSmithKline, LLC. $6.62 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116465974 GlaxoSmithKline, LLC. $13.39 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116466404 GlaxoSmithKline, LLC. $4.06 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116496054 GlaxoSmithKline, LLC. $2.54 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116509771 GlaxoSmithKline, LLC. $18.57 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116559137 GlaxoSmithKline, LLC. $16.16 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116605206 GlaxoSmithKline, LLC. $10.53 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116630712 GlaxoSmithKline, LLC. $5.87 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116651865 GlaxoSmithKline, LLC. $8.51 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117228525 Amgen Inc. $15.30 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131010244 PFIZER INC. $19.14 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131369194 PFIZER INC. $16.91 04/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135747612 Lilly USA, LLC $18.01 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135747614 Lilly USA, LLC $18.15 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139464034 Astellas Pharma US Inc $18.70 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139504447 Astellas Pharma US Inc $74.99 02/23/2024 Education Undisputed 01/23/2026 View at CMS
1139526216 Astellas Pharma US Inc $17.85 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141734681 Merck Sharp & Dohme LLC $21.09 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143412026 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.89 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151157129 Phathom Pharmaceuticals, Inc. $20.41 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151157131 Phathom Pharmaceuticals, Inc. $15.16 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151157133 Phathom Pharmaceuticals, Inc. $17.50 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153547873 Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.74 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153653638 Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.88 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.